SCHEMBL13601401

SCHEMBL13601401

CCCOC(=O)CCN1CCC(C2CCN(C(=O)[C@H](C)Cc3cc(C)c4[nH]c(=O)oc4c3)CC2)CC1

nearest known ligand 0.32

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CALCRL Q16602 4/20 0.32
CYP3A4 P08684 3/20 0.32
ENPP2 Q13822 4/20 0.32
KCNH2 Q12809 1/20 0.32
SMYD3 Q9H7B4 1/20 0.32
GRIN2D O15399 1/20 0.32
GRIN3B O60391 1/20 0.32
GRIN1 Q05586 1/20 0.32
GRIN2A Q12879 1/20 0.32
GRIN2B Q13224 1/20 0.32
GRIN2C Q14957 1/20 0.32
GRIN3A Q8TCU5 1/20 0.32
LMNA P02545 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
TP53 P04637 1/20 0.30
ADAM17 P78536 1/20 0.30
ADAMTS5 Q9UNA0 1/20 0.30
ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13601494 0.92 CALCRL (0.38) CALCRLCYP3A4ENPP2
SCHEMBL13601448 0.86 CALCRL (0.38) CALCRLCYP3A4ENPP2SMN1; SMN2ALDH1A1
SCHEMBL13601492 0.86 CALCRL (0.39) CALCRLCYP3A4ENPP2SMN1; SMN2ALDH1A1
SCHEMBL13601340 0.84 CALCRL (0.36) CALCRLCYP3A4ENPP2
SCHEMBL13601382 0.84 CALCRL (0.37) CALCRLCYP3A4
SCHEMBL13601533 0.80 KMT2A (0.39) CALCRLCYP3A4SMYD3SMN1; SMN2ALDH1A1
SCHEMBL13601342 0.79 CALCRL (0.35) CALCRLCYP3A4ENPP2
SCHEMBL13601383 0.79 CALCRL (0.36) CALCRLCYP3A4
SCHEMBL13601574 0.79 CALCRL (0.35) CALCRLCYP3A4SMYD3ALDH1A1
SCHEMBL13601557 0.79 CALCRL (0.35) CALCRLCYP3A4SMYD3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7625886-B2 Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-12-01 US disclosed
US-7625886-B2 Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-12-01 US disclosed